Literature DB >> 15742420

Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant.

Sheng Xiong1, Yi-Fei Wang, Xiang-Rong Ren, Bing Li, Mei-Ying Zhang, Yong Luo, Ling Zhang, Qiu-Ling Xie, Kuan-Yuan Su.   

Abstract

AIM: To study the influence of redox environment of Escherichia coli (E. coli) cytoplasm on disulfide bond formation of recombinant proteins.
METHODS: Bovine fibroblast growth factor (BbFGF) was selected as a model of simple proteins with a single disulfide bond and free cysteines. Anti-HBsAg single-chain Fv (HBscFv), an artificial multidomain protein, was selected as the model molecule of complex protein with 2 disulfide bonds. A BbFGF-producing plasmid, pJN-BbFGF, and a HBscFv producing-plasmid, pQE-HBscFv, were constructed and transformed into E. coli strains BL21(DE3) and M15(pREP4) respectively. At the same time, both plasmids were transformed into a reductase-deficient host strain, E. coli Origami(DE3). The 4 recombinant E. coli strains were cultured and the target proteins were purified. Solubility and bioactivity of recombinant BbFGF and HBscFv produced in different host strains were analyzed and compared respectively.
RESULTS: All recombinant E. coli strains could efficiently produce target proteins. The level of BbFGF in BL21(DE3) was 15-23% of the total protein, and was 5-10% in Origami (DE3). In addition, 65% of the BbFGF produced in BL21(DE3) formed into inclusion body in the cytoplasm, and all the target proteins became soluble in Origami(DE3). The bioactivity of BbFGF purified from Origami(DE3) was higher than its counterpart from BL21(DE3). The ED(50) of BbFGF from Origami(DE3) and BL21(DE3) was 1.6 microg/L and 2.2 microg/L, respectively. Both HBscFv formed into inclusion body in the cytoplasm of M15(pQE-HBscFv) or Origami(pQE-HBscFv). But the supernatant of Origami(pQE-HBscFv) lysate displayed weak bioactivity and its counterpart from M15(pQE-HBscFv) did not display any bioactivity. The soluble HBscFv in Origami(pQE-HBscFv) was purified to be 1-2 mg/L and its affinity constant was determined to be 2.62 x 10(7) mol/L. The yield of native HBscFv refolded from inclusion body in M15(pQE-HBscFv) was 30-35 mg/L and the affinity constant was 1.98 x 10(7) mol/L. There was no significant difference between the bioactivity of HBscFvs refolded from the inclusion bodies produced in different host strains.
CONCLUSION: Modification of the redox environment of E. coli cytoplasm can significantly improve the folding of recombinant disulfide-bonded proteins produced in it.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742420      PMCID: PMC4250777          DOI: 10.3748/wjg.v11.i7.1077

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm.

Authors:  P Martineau; J M Betton
Journal:  J Mol Biol       Date:  1999-10-01       Impact factor: 5.469

Review 2.  Engineering therapeutic proteins.

Authors:  J McCafferty; D R Glover
Journal:  Curr Opin Struct Biol       Date:  2000-08       Impact factor: 6.809

3.  [Expression of a human single-chain Fv antibody against HBsAg in Pichia pastoris].

Authors:  Sheng Xiong; Xiang-Rong Ren; Yong-Hong Tang; Kuan-Yuan Su; Zhou-Yao Yu; Yong Luo; Yi-Fei Wang; Jiu-Xiang Li
Journal:  Sheng Wu Gong Cheng Xue Bao       Date:  2003-01

4.  Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay.

Authors:  J D Beatty; B G Beatty; W G Vlahos
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

5.  The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm.

Authors:  W A Prinz; F Aslund; A Holmgren; J Beckwith
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

6.  Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm.

Authors:  P H Bessette; F Aslund; J Beckwith; G Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Expression and purification of a biologically active basic fibroblast growth factor fusion protein.

Authors:  Zhi Sheng; Shin-Bey Chang; William J Chirico
Journal:  Protein Expr Purif       Date:  2003-02       Impact factor: 1.650

8.  Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants.

Authors:  Nadia Ramírez; Marta Ayala; Damaryst Lorenzo; Daniel Palenzuela; Lissett Herrera; Vivian Doreste; Marlene Pérez; Jorge V Gavilond; Pedro Oramas
Journal:  Transgenic Res       Date:  2002-02       Impact factor: 2.788

9.  Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures.

Authors:  Qiang Hua; Chen Yang; Taku Oshima; Hirotada Mori; Kazuyuki Shimizu
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

10.  Expression and assembly of a fully active antibody in algae.

Authors:  Stephen P Mayfield; Scott E Franklin; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-08       Impact factor: 11.205

View more
  7 in total

1.  Functional recombinant extra membrane loop of human CD20, an alternative of the full length CD20 antigen.

Authors:  Mahdi Habibi Anbouhi; Aida Feiz Barazandeh; Saeid Bouzari; Mohsen Abolhassani; Hossein Khanahmad; Majid Golkar; Mohammad Reza Aghasadeghi; Mahdi Behdani; Ali Jahanian-Najafabadi; Mohammad Ali Shokrgozar
Journal:  Iran Biomed J       Date:  2012

2.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

3.  Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.

Authors:  Christopher A Lino; Jerri C Caldeira; David S Peabody
Journal:  J Nanobiotechnology       Date:  2017-02-13       Impact factor: 10.435

Review 4.  Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications.

Authors:  Arshpreet Bhatwa; Weijun Wang; Yousef I Hassan; Nadine Abraham; Xiu-Zhen Li; Ting Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-02-10

5.  Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library.

Authors:  Nasir Shams; Shahryar Khoshtinat Nikkhoi; Zhanjun Gu; Fatemeh Rahbarizadeh
Journal:  Med Oncol       Date:  2022-08-23       Impact factor: 3.738

Review 6.  Toxins from cone snails: properties, applications and biotechnological production.

Authors:  Stefan Becker; Heinrich Terlau
Journal:  Appl Microbiol Biotechnol       Date:  2008-03-14       Impact factor: 4.813

7.  High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli.

Authors:  Hervé Nozach; Carole Fruchart-Gaillard; François Fenaille; Fabrice Beau; Oscar Henrique Pereira Ramos; Badreddine Douzi; Natalie J Saez; Mireille Moutiez; Denis Servent; Muriel Gondry; Robert Thaï; Philippe Cuniasse; Renaud Vincentelli; Vincent Dive
Journal:  Microb Cell Fact       Date:  2013-04-22       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.